Author: digi

Isolator Leak Testing, Sanitization and Decontamination: Regulatory Expectations Isolator Leak Testing, Sanitization and Decontamination: A Step-by-Step Guide for Annex 1 Compliance Isolators constitute a critical component of contamination control strategies within aseptic manufacturing environments, ensuring sterility assurance and protection of sterile products from environmental contaminants. The regulatory landscape governing isolator operation, including leak testing, sanitization,…

Read More “Isolator Leak Testing, Sanitization and Decontamination: Regulatory Expectations” »

Designing Aseptic Process Simulations (Media Fills) Under Annex 1 Step-by-Step Guide to Designing Aseptic Process Simulations (Media Fills) Under Annex 1 Aseptic manufacturing is critical for the production of sterile pharmaceutical products intended for parenteral administration. The need for stringent contamination control and thorough validation of aseptic processes is emphasized in regulatory frameworks such as…

Read More “Designing Aseptic Process Simulations (Media Fills) Under Annex 1” »

CCS for Non-Sterile Manufacturing: Is Annex 1 Still Relevant? Cleanroom Contamination Control Strategy (CCS) for Non-Sterile Manufacturing: Assessing the Relevance of Annex 1 In the pharmaceutical manufacturing landscape, contamination control remains paramount to ensure drug product quality and patient safety. While Annex 1 to the EU GMP guidelines specifically addresses aseptic manufacturing and sterilised medicinal…

Read More “CCS for Non-Sterile Manufacturing: Is Annex 1 Still Relevant?” »

Contamination Control for Terminally Sterilized Products: Focus Areas Beyond Sterilization Contamination Control for Terminally Sterilized Products: Comprehensive Guide Beyond Sterilization In sterile pharmaceutical manufacturing, terminal sterilization offers a robust method to ensure the sterility assurance of finished products. However, the regulatory guidelines including EU GMP Annex 1 emphasize that contamination control measures extend significantly beyond…

Read More “Contamination Control for Terminally Sterilized Products: Focus Areas Beyond Sterilization” »

Container Closure Integrity Testing (CCIT) as a Contamination Barrier Ensuring Aseptic Manufacturing Through Container Closure Integrity Testing Container Closure Integrity Testing (CCIT) is a cornerstone in pharmaceutical sterile manufacturing, providing a critical barrier against contamination and ensuring sterility assurance throughout product shelf life. This detailed step-by-step GMP tutorial explores how CCIT integrates into contamination control…

Read More “Container Closure Integrity Testing (CCIT) as a Contamination Barrier” »

Managing Material Transfer Into Aseptic Areas: Double-Bagging, Decontamination and Flow Effective Management of Material Transfer Into Aseptic Areas: A Step-by-Step Guide In the pharmaceutical industry, contamination control during aseptic manufacturing is critical to ensuring patient safety and product sterility assurance. A key aspect of contamination control involves the proper transfer of materials into aseptic environments—usually…

Read More “Managing Material Transfer Into Aseptic Areas: Double-Bagging, Decontamination and Flow” »

Use of Transfer Hatches, Pass-Throughs and RTP Ports in Contamination Control Best Practices for Transfer Hatches, Pass-Throughs, and RTP Ports in Aseptic Manufacturing In the context of aseptic manufacturing environments, controlling contamination is paramount to maintaining product sterility assurance. Critical to this control are the physical interfaces used for material transfer into cleanrooms—specifically transfer hatches,…

Read More “Use of Transfer Hatches, Pass-Throughs and RTP Ports in Contamination Control” »

Disinfectant Efficacy Studies: Suspension Tests, Surface Tests and Annex 1 Alignment Disinfectant Efficacy Studies: Suspension Tests, Surface Tests and Annex 1 Alignment In pharmaceutical aseptic manufacturing, contamination control remains paramount to ensure patient safety and product sterility assurance. Disinfectant efficacy studies, including suspension and surface tests, are critical tools in validating cleaning protocols and contamination…

Read More “Disinfectant Efficacy Studies: Suspension Tests, Surface Tests and Annex 1 Alignment” »

Using Sporocides: How Often, Where and With What Justification Using Sporocides in Aseptic Manufacturing: Frequency, Application Areas, and Justification Based on Annex 1 and Contamination Control Principles In sterile pharmaceutical manufacturing, ensuring sterility assurance through effective contamination control is paramount. Sporicides play a vital role in controlling resistant microbial spores that conventional disinfectants cannot reliably…

Read More “Using Sporocides: How Often, Where and With What Justification” »

Controlling and Trending Environmental Isolates in Aseptic Facilities Effective Control and Trending of Environmental Isolates in Aseptic Manufacturing Facilities Ensuring sterility assurance in aseptic manufacturing hinges on stringent contamination control measures, particularly through robust environmental monitoring (EM) programs aligned with regulatory expectations such as Annex 1. This article provides a comprehensive, step-by-step tutorial tailored for…

Read More “Controlling and Trending Environmental Isolates in Aseptic Facilities” »